Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Gilead announces phase II/III results for influenza neuraminidase inhibitor

July 8, 1998

Broad-spectrum antiviral compounds prepared at Astra

July 8, 1998

Toyama describes novel cephalosporins for oral administration

July 6, 1998

Novel antifungal compounds, kinase inhibitors discovered by Shionogi

July 6, 1998

Scriptgen subscribes to Genome Therapeutics' PathoGenome database

July 6, 1998

Daiichi's new antibacterial agents

July 2, 1998

Zinc lozenges prove ineffective in treating common cold symptoms in children

July 1, 1998

Avax patents antifungal agents with novel mechanism of action

July 1, 1998

Neuprex receives orphan drug designation for treatment of severe meningococcal disease

June 29, 1998

Interference with production of virulence factors as novel antibacterial strategy

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...